Clinical Trial Update: 68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a Gallium-68 PSMA radiotracer for advanced hepatocellular carcinoma has completed; the document does not provide trial results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Gallium-68 PSMA radiotracer (Gallium-68 labeled PSMA ligand)

Snippet

Sponsor: Mayo Clinic | Conditions: Advanced Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8 | Phase 2 | Status: COMPLETED